Canadian Adverse Health Events from COVID-19 Vaccines and COVID-19 Statistics – April 20, 2021

 

Author: Tracey Young. (April 20, 2021). Canadian Adverse Health Events from COVID-19 Vaccines and COVID-19 Statistics – April 20, 2021. Canadian Advocacy Centre for Health, Safety and Justice. Retrieved from: https://canadianadvocacycentre.blogspot.com/2021/04/canadian-adverse-health-events-from_20.html.

Introduction

COVID-19 Vaccines have been getting administered in Canada since December 2020. Around the world countries are reporting a staggering range of post-vaccine Adverse Health events, and deaths associated with all of the COVID-19 vaccines that have received Interim, or Emergency authorization in their respective countries. 

The Canadian government has reported 31 deaths have occurred after COVID19 vaccines were administered in Canada. Upon further medical investigation and review, the Canadian government reported 16 deaths were not associated with the COVID-19 vaccine. They have also reported 15 of these deaths continue to be under investigation. Anecdotal reports of post-vaccine deaths are being reported across Canada. Official statistical data being reported in Canada does not appear to be capturing all of the post-vaccine AEFI's, or mortalities. 

In this article I will provide an overview of Canadian government statistical data and information about Adverse Events Following Immunization (AEFI) with COVID-19 vaccines, vaccine injuries and reactions that have been associated with these vaccines up to April 9th, 2021. 

Figure 4. Most frequently reported adverse events up to and including April 9, 2021 (n=10,111)

Canada: COVID Vaccines: Adverse Events Following Immunization (AEFI) Statistical Data and Information

COVID-19 Vaccine Safety - Government of Canada

Source: https://health-infobase.canada.ca/covid-19/vaccine-safety/

Adverse Events Following Immunization (AEFI) Statistical Data

Dates: From mid-December 2020 – April 9^th, 2021

Note: Detailed AEFI Breakdowns can be found under Figure 4 (scroll down to the bottom of the page and click on the link).

⮚ COVD Vaccine Doses Administered in Canada: 7,569,321

• Previous: Feb. 12th: 1,221,539; Feb. 19th: 1,402,139; Feb. 26th:1,778,405; March 5th: 2,255,174; March 12th: 2,830,164; March 19th: 3,729,312; March 26th: 4,800,931; April 2nd: 5,897,445

⮚ 3,444 AEFI’s (.045% of all doses administered); 

• Previous: Feb. 12th: 957; Feb. 19th: 1235; ; Feb. 26th:1591; March 5th: 1923; March 12th: 1922; ; March 19th: 2,530; March 26th: 2,859; April 2nd: 3,089

⮚ 31 Deaths 

• 16 reported to not be linked to vaccine; 15 are still under investigation
• Previous: March 26th: 24 (13 not linked; 15 under investigation); April 2nd: 27 (16 reported to not be linked to vaccine; 11 are still under investigation)

⮚ 464 Serious AEFI’s (.006% of all doses administered); 6.1 reports per 100,000 doses administered.

• Previous: Feb. 12th: 140; Feb. 19th: 167; Feb. 26th:194; ; March 5th: 214; March 12th: 287; March 19th: 320; March 26th: 384; April 2nd: 421

⮚ 2,980 Non-serious AEFI’s (.039% of all doses administered); 

• Previous: Feb. 12th: 817Feb. 19th:1068; Feb. 26th:1397; ; March 5th:1709; March 12th:1922; March 19th: 2,210; March 26th: 2,475; April 2nd: 2,668

⮚ 138 New Adverse events reported in the last week

• Previous: March 26th: 247; April 2nd:182

⮚ # of reported adverse events was highest among females and those aged 18 to 49.

⮚ 45.5 reports per 100,000 doses administered (out of a total of 3,444 reports) up to and including April 9, 2021.

Figure 2. Number of adverse event reports by vaccine name up to andincluding April 9, 2021 (n=3,444*)

Definition of Serious AEFI:

An event is considered serious if it:

• results in death
• is life-threatening (an event/reaction in which the patient was at real, rather than hypothetical, risk of death at the time of the event/reaction)
• requires in-patient hospitalization or prolongation of existing hospitalization
• results in persistent or significant disability/incapacity, or
• results in a congenital anomaly/birth defect

Anaphylaxis: Among the 464 serious reports, the most frequently reported adverse event was anaphylaxis.

Special Note Regarding AstraZeneca COVID-19 vaccine: There have been reports in Europe of blood clots associated with low levels of blood platelets (thrombocytopenia) following vaccination with the AstraZeneca COVID-19 vaccine. 

⮚ Following European reports of blood clots associated with low levels of blood platelets (thrombocytopenia), the National Advisory Committee on Immunization and the Chief Medical Officers of Health recently recommended that AstraZeneca COVID-19 vaccines should not be used in adults under age 55.

Source: Government of Canada. (April 20, 2021). Coronavirus Disease (COVID-19) Epidemiology Update. Retrieved from: https://health-infobase.canada.ca/covid-19/vaccine-safety/. 

Canadian COVID-19 Statistics: April 20, 2021

➤ 3% of Canadians have been diagnosed with COVID-19 in 1+ year

➤️.2% Active cases in the Canadian population

➤ 90% Recovered 

➤ 5% hospitalization rate

➤ ️3.9% rate of positive of 30+ million Canadians tested

➤️ .06% of Canadian population have been reported to die with COVID-19

➤ 96% of those who have died with CV-19 were over 60 years old, with pre-existing health conditions that are associated with more severe cases

Figure 3. Adverse event reports by age group up to and including April 9, 2021

Miscellaneous COVID-19 Vaccine Data

Front line Worker Testimonies: COVID-19 Vaccine Adverse Reactions. Retrieved from: https://drive.google.com/file/d/1YK0JR_lFy88Zu3rcC3L5NvL_Xr3ib6zY/view.

Copyright © 2021.Tracey Young/Canadian Advocacy Centre for Health, Safety and Justice. All Rights Reserved.
_________________________________________________

#COVID19 #COVID19Canada #COVIDvaccines #COVID19vaccines #Canada #DutytoWarn #HealthPromotion #HealthPrevention #InformedConsent #cdnpoli #canpoli